عنوان
پدید آورنده
موضوع
رده
RM301.27 .E84 2012
RM301
.
27
.
E84
2012
کتابخانه
محل استقرار
0309218136 (pbk. : alk. paper)
0309218144 (PDF)
9780309218139 (pbk. : alk. paper)
9780309218146 (PDF)
b510897
Ethical and scientific issues in studying the safety of approved drugs /
[Book]
Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
Washington, D.C. :
National Academies Press,
[2012]
©2012
xvi, 275 pages :
illustrations ;
23 cm
Includes bibliographical references
Incorporating benefit and risk assessment and benefit/risk management into food and drug administration decision-making -- Evidence and decision-making -- Selection and oversight of required postmarketing studies -- Synthesis
0
Clinical trials-- Moral and ethical aspects-- United States
Drug approval-- United States
Drugs-- Testing-- Moral and ethical aspects-- United States
Clinical Trials as Topic-- ethics
Drug Approval
Drug Evaluation-- ethics
Product Surveillance, Postmarketing-- methods
United States
2
174
.
2/951
23
RM301
.
27
.
E84
2012
2012
H-106
QV
771
Institute of Medicine (U.S.)., Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs
20160203201040.0
مطالعه متن کتاب [Book]
Y
